Wellington Partners
Helios now provides its approx. 12,000 employed physicians with free access to the knowledge platform Amboss. This gives physicians the opportunity to receive answers to clinical questions on the basis of specific diagnostic and therapeutic recommendations at any time via their smartphone or computer.
Immatics today announced the appointment of Thomas Ulmer as Chief Financial Officer, effective April 1st, 2018. Thomas Ulmer joins Immatics from the Merck Group, where he is currently Chief Financial Officer of the Allergopharma Business Unit.
Themis announced the close of a Series C financing round led by Global Health Investment Fund (GHIF) as a new investor in the company. Glenn Rockman, Partner at GHIF, will join Themis’ Supervisory Board. The Series C proceeds will be used to advance Themis’ clinical and pre-clinical vaccine development programs.
Page 4 of 17
